Menu

Provisional Program - Concurrent Session Three

  • Thursday 05 March, 2020
  • 07:30-17:45

SESSION ONE

07:30 Official Opening
08:00 Interesting cases
09:30 KEYNOTE LECTURE 1: Thyroid surgery for differentiated thyroid cancer: Recent advances and the future

10:00-10:30 Morning tea with industry

SESSION TWO: FREE PAPERS 2
10:00-12:00 Nine minute presentations followed by three minutes Q+A

12:00 KEYNOTE LECTURE 2: Technological advances for safer thyroidectomy

12:30-13:30 Lunch with industry

SESSION THREE: BENIGN THYROID DISEASE

14:05 TIRADS: Are we overdosing?
14:20 Do patients with MNG need surveillance?
14:35 Is TTx the treatment of choice for Grave's disease (rather than RAI)?
14:50 Role of surgery in patients with Hashimoto's thyroiditis: Pros and cons
15:05 Dealing with parathyroids during and after total thyroidectomy
15:20 Discussion

15:30-16:00 Afternoon tea with industry

SESSION FOUR: MEDULLARY THYROID CANCER

16:00 Differences in the management of DTC and MTC (and challenges in pre-op diagnosis of MTC)
16:15 Role of LN dissection for MTC
16:30 Molecular updates on MEN2
16:45 MTC recurrence: Concepts and treatment goals
17:00 Discussion

17:15 PERSPECTIVE: Extent of surgery for DTC < 4cm

17:45 DAY ONE CLOSE